Best of ASCO - 2014 Annual Meeting

 

Welcome

Outcomes

Health Services Research, Clinical Informatics, and Quality of Care

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A conundrum in cancer quality measurement: Performance on long-term survival reflects performance a long time ago.

Allison Lipitz-Snyderman

e18222

A living systematic review of immune checkpoint inhibitors in cancer patients: A novel platform for evidence synthesis in oncology.

Irbaz Bin Riaz

6596

A nationwide study for patterns of immune thrombocytopenia treatment in patients with chronic lymphocytic leukemia.

Suheil Albert Atallah-Yunes

e18193

A systematic review of surrogate endpoints (SEPs) for overall survival (OS) in metastatic colorectal cancer (mCRC).

Seerat Anand

e18206

Adherence and cumulative bisphosphonate dose in relation to risk of skeletal-related events among older patients with multiple myeloma.

Jifang Zhou

e18250

Analysis of racial distribution amongst patients in phase III cancer clinical trials.

Swathi Gopishetty

6588

Association between age, risk of severe (Grade 3-4) immune-related adverse events (sirAE), and mortality in patients receiving immune checkpoint inhibitors (ICI).

Asrar Alahmadi

6597

Association of sex, age and ECOG performance status with cancer immunotherapy efficacy in randomized controlled trials.

Fang Yang

6592

Can high-volume surgeons achieve optimal outcomes at low-volume hospitals? Implications for the Leapfrog Initiative and regionalization of high-risk surgical oncology procedures.

Christopher Thomas Aquina

6585

Caveat medicus: Harrowing experiences of clinicians who identify and publish near-fatal oncology associated adverse drug reactions.

Ashley Caitlin Godwin

6584

Clinical and molecular characteristics of non-small cell lung cancer patients from rural Maine.

Antoine Harb

e18237

Clinical outcomes and cost-effectiveness of breast cancer screening for childhood cancer survivors treated with chest radiation: A comparative modeling study.

Jennifer Yeh

6525

Clinical utility and reimbursement for expanded genomic panel testing in adult oncology.

Susan Jean Hsiao

6593

Comparative effectiveness of proton therapy versus photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer.

Brian Christopher Baumann

6521

Current treatment patterns and associated outcomes in Waldenström macroglobulinemia (WM) and related hematologic malignancies: A systematic literature review (SLR).

Boxiong Tang

e18235

Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma.

Ali Alobaidi

e18232

Development and evaluation of a proxy for baseline ECOG PS in advanced non-small cell lung cancer (aNSCLC), bladder cancer (aBCa), and melanoma (aMM): An electronic health records (EHR) study.

Natalia Sadetsky

e18194

Diabetes mellitus: An adverse prognosis in cancer patients—Study of a cohort treated at Instituto Oncológico Henry Moore (IOHM).

Ernesto Gil Deza

e18212

Digitally captured step counts for evaluating performance status in advanced cancer patients: A single cohort, prospective trial (Digi-STEPS).

Gillian Gresham

TPS6651

Disparities in lung cancer outcomes for veterans with comorbid mental disorders.

Jacob E Berchuck

6577

Do oral antineoplastic treatment data differ between Concerto Health AI Definitive Oncology EMR and Symphony Claims Data?

Laura Kay Chu

e18180

Does adding claims to EMR data improve comorbidity burden capture? A Concerto Health AI Definitive Oncology Dataset and Symphony Linkage Study.

William Bruce Wong

e18186

Does the quality of patient-reported outcomes (PROs) assessment in randomized controlled trials (RCTs) differ across cancer types and over time? A pooled analysis of 610 RCTs published between 2004 and 2018.

Francesco Sparano

e18218

Effect of right censoring bias on survival analysis.

Enrique Barrajon

e18188

Effects of online education on the identification and management of immune-related adverse events over time.

Lori Keys Pender

e18224

Elucidation of qualitative patient-reported outcome (PRO) data using latent dirichlet allocation (LDA) in patients (pts) undergoing radical cystectomy.

Thomas Michael Atkinson

e18245

Emergency department visits for prescription and synthetic opioid overdoses among patients with cancer.

Vikram Jairam

6579

Employment outcomes and quality of life in patients with early breast cancer and their support persons: A dyadic study.

Christine M Veenstra

e18241

Estimation of U.S. patients with cancer who may respond to cytotoxic chemotherapy.

Edward Maldonado

e18228

Evaluation of Electronic Activity Monitors (EAMs) during phase I clinical trials.

Mariana Scaranti

e18175

Evaluation of selective outcome reporting bias in efficacy endpoints in print and television advertisements for oncology drugs.

Cole Wayant

e18179

Factors associated with metastatic presentation in HPV-related squamous cell carcinoma of the head and neck (SCCHN): A National Cancer Database (NCDB) analysis.

Marta Brygida Bean

e18213

Factors associated with receipt and overall survival of concurrent chemoradiotherapy versus single modality therapy in unresectable stage III NSCLC.

Jorge E. Gomez

e18191

Flu vaccination rate of patients with severe immune-related adverse events.

Ian Matthew Allen

e18234

Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Delays in diagnosis and resulting effects on treatment allocation.

Dana Meredith Chase

e18195

HIV associated cancers.

Prabhjot Singh Bedi

e18254

Hormone replacement therapy (HRT) and risk of distant recurrence in newly diagnosed ER+, node-negative (N-) breast-cancer (BC) patients: A retrospective population-based matched-cohort study.

Ariel Hammerman

6591

Immune-related adverse events in melanoma: A nationwide analysis 2016.

Manoj P. Rai

e18253

Impact of cardiovascular comorbidities on mortality in patients admitted for neutropenic fever in 2016.

Suheil Albert Atallah-Yunes

6586

Impact of dental insurance coverage on presentation, long-term outcomes, and symptom burden in locally advanced head and neck cancer.

Alec Kacew

e18230

Impact of rates of referral and systemic therapy on 1-year outcomes in metastatic NSCLC: A real-world population based study.

Adam Michael Fundytus

e18238

Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence.

Ryan Nguyen

6578

Impact of the addition of bevacizumab (Bev) to chemotherapy on survival in metastatic colorectal cancer (MCRC): A real-world population-based analysis.

Sunand Nageswaran Kannappan

e18215

Impact of timing of palliative care team consults in patients with advanced cancer.

Thomas Bemis

e18182

Incidence and outcome of interval breast cancer among women participating in the provincial population based screening program in manitoba, Canada.

Saroj Niraula

6595

Inclusion of patient-reported outcomes (PROs) in randomized controlled trials (RCTs) with elderly cancer patients: A systematic review.

Francesco Sparano

e18217

Influence of timing of goals of care discussion on hospitalization outcomes in metastatic cancer patients.

Oluwadunni Emiloju

e18183

Inpatient outcome of solid tumor associated tumor lysis syndrome.

Zimu Gong

e18185

Is a delay in ALK inhibitor initiation associated with poorer survival? A retrospective analysis based on real-world data.

Daniel Sheinson

e18240

Is immunotherapy toxicity associated with improved overall survival among older adults with advanced cancer?

Andrew Johns

6580

Longitudinal toxicity analysis with novel summary metrics of lenalidomide maintenance in follicular lymphoma in ECOG-ACRIN 2408.

Gita Thanarajasingam

6511

Low nationwide utilization of adjuvant chemotherapy (AC) in elderly patients with localized non-small cell lung cancer (NSCLC).

Kaushal Parikh

6581

Lung cancer in African-Americans and analysis of estrogen plus progestin use.

Idoroenyi Usua Amanam

e18258

Meta-analysis of effect of hormone therapies on lipid levels in breast cancer patients.

Hsin-Hui Huang

e18243

Molecular and clinical features of hospital admissions and immunotherapy related adverse events of immune checkpoint inhibitors in thoracic malignancies.

Dan Zhao

e18192

Online education about lung cancer immunotherapy: Outcomes over time.

Lori Keys Pender

e18249

Opportunity for performance measurement: 30-day mortality following cancer surgeries across U.S. hospitals.

Allison Lipitz-Snyderman

e18221

Outcomes of immunotherapy administration for hospitalized cancer patients.

Houry Leblebjian

e18225

Patient characteristics, treatment received, and outcomes of non-metastatic breast cancer patients in Haiti: Report from retrospective cohort.

Temidayo Fadelu

e18196

Patient reported outcomes in cancer patients: Psychological, physical and functional importance.

Shiva Shrotriya

e18209

Patient-reported disease burden in chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma: Results from a national patient advocacy survey.

Mark Price

e18198

Perioperative therapy in patients with metastatic colorectal cancer.

Olatunji B. Alese

e18231

Population health impact of genome-driven oncology by race and ethnicity.

Fabrice Smieliauskas

e18229

Population kinetics of progression free survival (PFS).

David J. Stewart

e18251

Pregnancies in subjects on oncology clinical trials: Analysis from the Cancer Therapy Evaluation Program (CTEP) database.

Arjun Mittra

e18239

Pretreatment symptom prevalence in patients with myelodysplastic syndromes (MDS) across all disease risk categories: Analysis of 914 patients.

Fabio Efficace

e18220

Prospective study of pain outcomes associated with contralateral prophylactic mastectomy in women with nonhereditary breast cancer.

Demetria Joy Smith-Graziani

6587

Publication rate of registered clinical trials in lung cancer.

Ghassan Al-shbool

e18211

Quality of life (QOL) in patients undergoing CAR-T therapy versus stem cell transplant (SCT).

Surbhi Sidana

6594

Real-world effectiveness of approved anticancer agents among Medicare beneficiaries.

Angela Green

6589

Real-world evidence in the treatment of metastatic non-small cell lung cancer in a single institution of Colombia in the period August 2015 to August 2018.

Luis Eduardo Pino

e18204

Real-world prevalence of autoimmune disease (AD) among patients (pts) receiving immune checkpoint inhibitors (ICI) in ASCO’s CancerLinQ database.

Li Chen

6583

Real-world treatment patterns, survival, and cost among elderly cervical cancer patients.

Changxia Shao

e18226

Re-evaluating the neutrophil-to-lymphocyte ratio: Machine learning-based variable selection for predicting survival at twelve months in late-stage cancer patients receiving immunotherapy.

Daniel Spakowicz

e18201

Reporting of patient reported outcome (PRO) in clinical trials: A systematic review of clinical trials.

Liat Vidal-Fisher

6590

Responder analysis of patient-reported outcomes measurement information system (PROMIS) physical function (PF) and worst stiffness among patients with tenosynovial giant cell tumors (TGCT) in the ENLIVEN study.

William D. Tap

e18236

Risk of neutropenia-related hospitalization (NRH) related to duration of short-acting granulocyte colony stimulating factor (sG-CSF) for primary prophylaxis.

Shuling Li

e18181

Self-reported health and survival in older patients diagnosed with multiple myeloma.

Nadia Azmi Nabulsi

6582

Socioeconomic contributions to clinical outcome by HPV status in squamous cell carcinomas of the head and neck (SCCHN): An analysis of NCDB.

Jennifer Aline Marks

e18214

The burden of hyponatremia and hypercalcemia on hospitalizations and mortality in lung cancer patients in the United States: An analysis of nationwide inpatient database.

Sukriti Kamboj

e18256

The prognostic value of patient-reported outcomes (PROs) for survival outcomes in cancer patients: A systematic review.

Francesco Cottone

e18223

Trends in mortality due to hypercalcemia in breast cancer.

Stuthi Perimbeti

e18252

Trends in the incidence and outcomes of Clostridioidesdifficile infection in hematological cancers: A nationwide analysis.

Fateeha Furqan

e18244

Unveiling the real-world outcomes of breast cancer (BC) patients with taxanes-induced neuropathy using a digital patient-powered network (PPN).

Raanan Berger

e18248

Upper extremity deep venous thrombosis in 10 common malignancies: Analysis of incidence, risk factors, and effect on mortality from the California Cancer Registry.

Christina Poh

e18190

Utilization and outcomes of high-dose chemotherapy and stem-cell rescue in patient with testicular cancer from 2005 to 2014 in United States.

Aakash Desai

e18246

Valuing innovations in cancer treatment.

Henu Zhao

e18176

Variations in patient-reported outcome (PRO) collection and reporting in novel FDA approved anticancer therapies.

Surbhi Singhal

e18202

Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors.

Lorenzo Gervaso

e18184

Vitamin D status and survival in patients with triple negative breast cancer.

John Khoury

e18210